Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 4/20 | 0.63 |
| ▸ | ACHE | P22303 | 1/20 | 0.63 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.63 |
| ▸ | TDO2 | P48775 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | GABRP | O00591 | 1/20 | 0.59 |
| ▸ | GABRD | O14764 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29927826 | 1.00 | BCHE (0.63) | BCHEACHEDYRK1ATDO2KDM4E | |
| SCHEMBL28661144 | 0.87 | BCHE (0.69) | BCHETDO2KDM4EMEN1MAPT | |
| SCHEMBL933660 | 0.86 | BCHE (0.60) | BCHEDYRK1ATDO2KDM4EMEN1 | |
| SCHEMBL29611964 | 0.84 | BRAF (0.61) | BCHETDO2KDM4EMEN1MAPT | |
| SCHEMBL1218770 | 0.84 | BRAF (0.61) | BCHETDO2KDM4EMEN1MAPT | |
| Hydrochloric Acid SCHEMBL6239184 | 0.84 | BCHE (0.59) | BCHEDYRK1ATDO2KDM4EMEN1 | |
| SCHEMBL5080656 | 0.84 | BCHE (0.55) | BCHEACHEDYRK1ATDO2KDM4E | |
| SCHEMBL27929500 | 0.83 | BCHE (0.57) | BCHETDO2KDM4EMEN1MAPT | |
| Hydrochloric Acid SCHEMBL27734884 | 0.82 | BCHE (0.54) | BCHEACHEDYRK1ATDO2KDM4E | |
| SCHEMBL5850711 | 0.82 | BCHE (0.56) | BCHETDO2KDM4EMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2926119-B1 | METHOD OF MARKING OF MATERIAL, MARKED MATERIAL AND METHOD FOR AUTHENTICATING A MATERIAL | SICPA HOLDING SA (CH) | 2023-02-22 | — | — | EP | claimed |
| CN-109528718-B | Medicine for treating cervical cancer and application thereof | 孙凤永 | 2020-11-24 | — | — | CN | claimed |
| EP-2926119-A1 | MARKING OF MATERIAL, MARKED MATERIAL AND PROCESS OF AUTHENTICATION OR DILUTION DETERMINATION | Sicpa Holding SA (CH) | 2015-10-07 | — | — | EP | claimed |
| US-20140154813-A1 | MARKING OF MATERIAL, MARKED MATERIAL AND PROCESS OF AUTHENTICATION OR DILUTION DETERMINATION | SICPA HOLDING SA (CH) | 2014-06-05 | — | — | US | claimed |
| WO-2014083145-A1 | MARKING OF MATERIAL, MARKED MATERIAL AND PROCESS OF AUTHENTICATION OR DILUTION DETERMINATION | SICPA HOLDING SA (CH) | 2014-06-05 | — | — | WO | claimed |
| CN-103374056-A | 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-10-30 | — | — | CN | claimed |
| US-8313934-B2 | Use of hydrophobic solvent immisible from fermentation broth; hydrocarbon biosynthesis of e.g. biodiesel fuels; kits, vehicles, biofuel product | LS9, INC. (US) | 2012-11-20 | — | — | US | claimed |
| US-20090084025-A1 | REDUCTION OF THE TOXIC EFFECT OF IMPURITIES FROM RAW MATERIALS BY EXTRACTIVE FERMENTATION | LS9,INC. (US) | 2009-04-02 | — | — | US | claimed |
| WO-2009042950-A1 | REDUCTION OF THE TOXIC EFFECT OF IMPURITIES FROM RAW MATERIALS BY EXTRACTIVE FERMENTATION | LS9, INC. (US) | 2009-04-02 | — | — | WO | claimed |
| CN-121674282-A | Method for preparing ultraviolet absorbent by utilizing Gong Pi live cocci Dermacoccus nishinomiyaensis and application | 上海交通大学三亚崖州湾深海科技研究院 | 2026-03-17 | — | — | CN | disclosed |
| CN-120000749-A | Traditional Chinese medicine composition for treating idiopathic pulmonary fibrosis as well as preparation method and application thereof | 广州中医药大学第一附属医院 | 2025-05-16 | — | — | CN | disclosed |
| WO-2023239842-A1 | BETA CARBOLINES AS TOPICAL ANTI-INFLAMMATORY AGENTS FOR APPLICATION TO MUCOUS MEMBRANES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-12-14 | — | — | WO | disclosed |
| CN-115184533-B | LC-MS method for quantitatively detecting golden bell oral liquid | 山东宏济堂制药集团股份有限公司 | 2023-06-20 | — | — | CN | disclosed |
| CN-115814004-A | Medicine composition for treating bone disease | 北京朕荣国际生物科技有限公司 | 2023-03-21 | — | — | CN | disclosed |
| US-20130172330-A1 | Chemokine Receptor Modulators | ALTIRIS THERAPEUTICS, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| CN-103083401-A | Compound pharmaceutical composition comprising szechwan lovage rhizome extract and caulis sinomenii extract | EX RES CT CHINA ACADEMY OF CHINESE MEDICAL SCIENCES | 2013-05-08 | — | — | CN | disclosed |
| US-8313934-B2 | Use of hydrophobic solvent immisible from fermentation broth; hydrocarbon biosynthesis of e.g. biodiesel fuels; kits, vehicles, biofuel product | LS9, INC. (US) | 2012-11-20 | — | — | US | disclosed |
| US-20090084025-A1 | REDUCTION OF THE TOXIC EFFECT OF IMPURITIES FROM RAW MATERIALS BY EXTRACTIVE FERMENTATION | LS9,INC. (US) | 2009-04-02 | — | — | US | disclosed |
| WO-2009042950-A1 | REDUCTION OF THE TOXIC EFFECT OF IMPURITIES FROM RAW MATERIALS BY EXTRACTIVE FERMENTATION | LS9, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| CN-1364586-A | Traditional Chinese medicine compound oral sticking film for coronary heart disease and angina pectoris | TIANYIN TEST ANIMAL CT (CN) | 2002-08-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172330-A1 | Chemokine Receptor Modulators | CCR5, CXCR4, ACKR3 | BCHE 4400/4885ACHE 4873/4885DYRK1A 3205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.